'13 Reasons Why' Suicide Spike; Sleeping Pill Warning; Bipolar Genes

— News and commentary from the psychiatry world

MedicalToday

Teen suicides spiked in the month following the release of the , with the association restricted to boys. (Journal of the American Academy of Child & Adolescent Psychiatry)

are rising among teenagers in the U.S. -- particularly among girls. (Journal of Pediatrics)

The FDA announced sleeping pills like zolpidem (Ambien) and eszopiclone (Lunesta) will now carry a black box warning about dangerous side effects, such as sleep driving. ()

Twenty genes were identified as being associated with . "By discovering new genes associated with bipolar disorder and demonstrating their overlap with genes found in other psychiatric disorders, we bring ourselves closer to finding the true genetic underpinnings of the disease and improving patient outcomes," said Eli Stahl, PhD, of the Icahn School of Medicine at Mount Sinai. (Nature Genetics)

Compared to non-pregnant women with depressive symptoms, were less likely to report receiving any mental health treatment -- 57% versus 49%, respectively. (Psychiatric Services)

Is the newest form of dementia? ()

Childhood obesity may be an independent risk factor for , according to new research presented at the European Congress on Obesity. "The next steps are to understand the implications of their co-occurrence and how to best intervene to promote good health," said co-lead author Praveetha Patalay, PhD, of University College London.

People with major depression might have reflecting lower dopamine signaling. (JAMA Psychiatry)

The FDA rejected Heron Therapeutics' new drug application for their -- an extended-release formulation of local anesthetic bupivacaine.

The U.K. Health Secretary announced all opioids in the U.K. will now carry . (BBC)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.